Cargando…
33.2 CAN THE STIGMATIZING RISKS OF THE ‘AT-RISK’ STATE BE REDUCED BY RELABELING IT ‘HIGH-RISK HEALTH’? PROMISING PILOT RESULTS FROM TWO EXPERIMENTAL VIGNETTE STUDIES AMONG THE GENERAL POPULATION AND MENTAL HEALTH PROFESSIONALS.
BACKGROUND: While there is a wide consensus regarding the potential benefits that early detection and intervention in clinical high-risk (CHR) states for psychosis might offer, application of this paradigm in current mental healthcare systems frequently involves concerns about the iatrogenic impact...
Autores principales: | Koren, Dan, Radin-Gilboa, Shulamit, Libas, Yulia, Carmi, Dana |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5887322/ http://dx.doi.org/10.1093/schbul/sby014.138 |
Ejemplares similares
-
Relabeling the Medications We Call Antidepressants
por: Antonuccio, David, et al.
Publicado: (2012) -
Language and stigmatization of individuals with mental health problems or substance addiction in the Netherlands: An experimental vignette study
por: Martinelli, Thomas F., et al.
Publicado: (2020) -
Personality, self-esteem, familiarity, and mental health stigmatization: a cross-sectional vignette-based study
por: Steiger, Sahar, et al.
Publicado: (2022) -
Unpacking the effects of adverse regulatory events: Evidence from pharmaceutical relabeling
por: Higgins, Matthew J., et al.
Publicado: (2021) -
Global chromatin relabeling accompanies spatial inversion of chromatin in rod photoreceptors
por: Smith, Cheryl L., et al.
Publicado: (2021)